Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8
2 clinical trials · Condition
◉ Watch Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer (NCT04929392) | City of Hope Medical Center | 2022-01-25 |
| Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer (NCT03776487) | M.D. Anderson Cancer Center | 2019-01-07 |
Track Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.